RUTW250515P1690000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
Rocket Pharmaceuticals Presents Preliminary Data From Phase 1 Clinical Trial Of RP-A601 For PKP2 Arrhythmogenic Cardiomyopathy At 28th Annual Meeting Of The American Society Of Gene And Cell Therapy
Top 10 Stocks According to Seeking Alpha's Quant Metrics
What's Going On With D-Wave Quantum Shares This Month?
A Look Into Aehr Test System Inc's Price Over Earnings
The Analyst Verdict: Merit Medical Systems In The Eyes Of 14 Experts
Is the Market Bullish or Bearish on CommVault Systems?
Expert Outlook: Build-A-Bear Workshop Through The Eyes Of 7 Analysts
Global Water Resources Targets $6.5M Rate Increase as Industrial and Multifamily Growth Continues
Taysha Gene Therapies Shares Are Trading Higher Following Q1 Earnings.
Boot Barn Enjoys a Degree of Stability Not Enjoyed by Retailers - Analysts
Fidelis Targets 10% Premium Growth for 2025 While Advancing Capital Management and Risk Mitigation
Trump Insiders Want A Piece Of Crypto, SPAC Action: Is A Merger Coming?
CoreWeave, Super Micro, Apple, Alibaba, UnitedHealth, Walmart, Foot Locker, Cisco, Deere: Biggest Movers
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $108
Alumis Analyst Ratings
Merit Medical Systems Analyst Ratings
Taysha Outlines Expedited Pivotal Trial Start for TSHA-102 Following FDA Alignment
Acrivon Therapeutics Analyst Ratings
Eli Lilly Sees Alzheimer's Drug Development Beyond Amyloid Beta Targeting
B. Riley Securities Maintains Buy on Alpha Metallurgical, Lowers Price Target to $181